We provide services and empower those affected by and living with viral hepatitis in Western Australia
We are thrilled to announce our new online portal that connects remote WA communities to hepatitis B care
HepBWA is a new online portal for multicultural, remote and regional WA Communities to learn about hepatitis B.
People in the Mid-West can now book telehealth appointments with HepatitisWA’s Deen Clinic for hepatitis B screening, diagnosis and treatment. No referral needed.
Scan to visit www.hepbwa.com.au
HEPATITIS C TESTING
•
RESULTS IN 1 HOUR
•
HEPATITIS C TESTING • RESULTS IN 1 HOUR •
The Deen Clinic now offers point of care (finger-prick) testing for Hepatitis C.
It is quick, easy and accurate.
Just walk in, no appointments needed.
HepatitisWA is a proud supporter of HepLink Australia
HepLink Australia provides confidential, free and localised viral hepatitis information and support services.
Call: 1800 437 222
How can HepLink Help?
Contact us at heplink@hepatitiswa.com.au or Call: 1800 437 222
Monday - Friday 9am - 5pm
HepLink Australia is available to anyone, anywhere in Australia, including:
People living with viral hepatitis including hepatitis B and hepatitis C
People who have previously had viral hepatitis
People at risk of viral hepatitis
Families or friends of a person living with, or at risk of, viral hepatitis
Health or social service workers
The general public
If you’re calling from Western Australia, you will be talking to a HepLink officer in Perth with knowledge about hepatitis and relevant services available in your area. HepatitisWA and The Deen Clinic are the Western Australian, Perth-based HepLink support service located at 134 Aberdeen Street, Northbridge WA 6003
Contact heplink@hepatitiswa.com.au to learn more about Perth’s local HepLink service or please visit https://www.heplink.au/
HepatitisWA Updates
World Hepatitis Day 2025 Media Release
On World Hepatitis Day 2025, NACCHO and Hepatitis Australia are calling for urgent national action to eliminate hepatitis B and C in Aboriginal and Torres Strait Islander communities. Their joint media release highlights the need to support community-led solutions, expand culturally safe care, and invest in proven programs that improve health outcomes. It’s time to back local leadership and ensure no one is left behind in the fight against viral hepatitis. Read the media release here
Advertising campaign to raise awareness of blood-borne viruses
The Department of Health has launched an advertising campaign to raise awareness of blood-borne viruses (BBVs), and the importance of BBV prevention among Aboriginal people aged 16-39 years. Blood-borne viruses – such as hepatitis B, hepatitis C and HIV– are transmitted by blood, and hepatitis B and HIV can also be transmitted through sexual activity (sexual transmission of hepatitis C is also possible if blood is present).
The campaign was developed in consultation with Aboriginal Health Workers and leaders from regional and metropolitan areas and community based organisations including a peer organisation for people who inject drugs. Interviews with Aboriginal people in WA that have a lived experience of hepatitis C and HIV also shaped the campaign development. People with blood-borne viruses often look and feel healthy, so encouraging people at risk to get tested is a key factor in addressing blood-borne viruses.
Hepatitis C notifications are disproportionally high in the Aboriginal population. In WA, hepatitis C notifications in Aboriginal people are 13-times higher than reported among non-Aboriginal people. Injecting drug use also contributes to a proportion of newly diagnosed HIV infections in WA. Testing is crucial as a range of treatments are now making it possible for people with blood-borne viruses to continue to live long and healthy lives. Treatments are now available through the Pharmaceutical Benefits Scheme. A cure is now possible for 95 percent of people with chronic hepatitis C.
Highly effective treatments are also available for people living with HIV. Encourage your clients and community to get tested for blood-borne viruses. For more information read about blood-borne viruses or go to lookafteryourblood.health.wa.gov.au
Naloxone saves lives
Recent overdose deaths raise fears for people in prison – naloxone must be made available to save lives.
Click here to read the media statement
What is naloxone?
Naloxone is a medicine that rapidly reverses an opioid overdose. It is an antagonist. This means that it attaches to opioid receptors and reverses and blocks the effects of other opioids. Naloxone can quickly restore normal breathing to a person if their breathing has slowed or stopped because of an opioid overdose.
How is naloxone given?
Naloxone should be given to any person who shows signs of an opioid overdose or when an overdose is suspected. Naloxone can be given as a spray or it can be injected into the muscle, under the skin, or in the veins.
What is Hepatitis?
The word hepatitis simply means inflammation (titis) of the liver (hepat). Hepatitis can be caused by viruses, harmful consumption of alcohol, drugs, medications, contact with some chemical and toxins, and some autoimmune conditions. The inflammation in the liver is your body’s natural reaction to the damage being caused by these conditions and toxins.